Drugs Channel
Topics & Medications
Related Channels


Carbinoxamine is an allergy medication approved to treat various types of allergies, including respiratory allergies, skin allergies, and eye allergies. It belongs to a class of drugs called antihistamines, and it works by blocking the effects of H1 receptors and acetylcholine receptors. The medicine is available by prescription only and comes in both tablet and liquid form. It is typically taken three or four times a day.

What Is Carbinoxamine?

Carbinoxamine maleate (Palgic®) is a prescription allergy medication. It is approved to treat a wide variety of allergies, such as eye allergies, skin allergies, or respiratory allergies (such as hay fever). When used along with other medications, it can even be used to treat very serious allergic reactions.
(Click What Is Carbinoxamine Used For? for more information, including possible off-label uses.)

Potential Side Effects

As with any medicine, carbinoxamine can cause side effects. However, not everyone who takes the drug will experience bothersome side effects. Some people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider. Serious side effects are less common.
Possible side effects of carbinoxamine include, but are not limited to:
  • Drowsiness
  • Dizziness
  • Coordination problems
  • Indigestion or heartburn.
(Click Side Effects of Carbinoxamine to learn more, including potentially serious side effects that you should report immediately to your healthcare provider.)
5 Tips to Keep a Cold at Bay

Carbinoxamine Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.